INO relative valueRV
INOVIO PHARMACEUTICALS, INC.. How this company compares with the rest of its GICS sub-industry on the figures it reported in its last annual filing.
INO's operating margin of -132871.3% ranks in the 7th percentile of 6 Biotechnology sub-industry peers, fiscal periods ending between 2025-06-30 and 2025-12-31.
As of . Source: SEC EDGAR XBRL company facts. Method and limitations.
Against 18 Biotechnology peers
| Metric | INO | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 65.3K USD | 817K USD | 39th | 8 |
| Revenue YoY | n/a | n/a | n/a | 1 |
| Gross margin | n/a | n/a | n/a | n/a |
| Operating margin | -132871.3% | -2002.3% | 7th | 6 |
| Net margin | -130000.0% | -2928.8% | 6th | 7 |
| Return on equity | -352.5% | -87.9% | 9th | 15 |
| P / E | n/a | n/a | n/a | 3 |
| 1 year | n/a | n/a | n/a | n/a |
Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Fiscal periods ending between 2025-06-30 and 2025-12-31. Prices as of 2026-09-18. Every figure is one full fiscal year from one filing. Nothing is trailing twelve months and nothing is converted between currencies. 0001055726-26-000008
Peer set, 18 companies
MIST, KZIA, HURA, OKUR, NMRA, CNTB, PMN, MNOV, BMEA, UNCY, NAUT, CBUS, BDTX, VTVT, VXRT, NRXP, ENGN, TNYA
Left out: CNXU (no annual filing), TLSA (period gap).
What could not be compared
- 68 The filer did not report this line in the filing used.
- 18 The price series does not reach back to the start of this window.
- 18 The denominator is zero or negative, so the ratio has no meaning.
- 4 Fewer than 5 peers carry a comparable value, so no median, quartile or percentile is published.
- 2 The newest price is more than 10 days old.
- 1 This filer reports an ordinary share count and trades as a depositary receipt at a ratio Kresmion does not store, so price times shares would be wrong.
- 1 Reported in a different currency than the subject. A level in another currency is not comparable and is not converted here.
- 1 No annual filing (10-K, 20-F or 40-F) with fiscal-year figures.
- 1 This company's fiscal year ends more than 200 days from the subject's, so it is a different economic year.
Free account
Open the relative value desk with a free account
An account turns this page into a research desk: thirty-one metrics over the whole peer set instead of eight, the distribution behind each median, the metric's history against the peer band, an editable peer set, the filing behind every cell, and CSV. The table above stays free.
Cite this data
Each figure is the full fiscal year reported on one annual SEC filing (10-K, 20-F or 40-F), named by accession. Peers are the company's GICS sub-industry. A median, quartile or percentile is published only when at least five peers carry a comparable value, and a peer reporting in another currency is excluded from a level rather than converted.
Upstream: SEC EDGAR XBRL company facts
Kresmion, "INO relative value, Kresmion", data as of 2026-03-12, https://kresmion.com/tools/relative-value/INO. Upstream data: SEC EDGAR XBRL company facts.